Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Rockwell Medical (RMTI) over the last 17 years, with Q3 2025 value amounting to $23000.0.

  • Rockwell Medical's Change in Account Payables rose 10310.81% to $23000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 million, marking a year-over-year increase of 1815.43%. This contributed to the annual value of -$1.6 million for FY2024, which is 45572.35% down from last year.
  • As of Q3 2025, Rockwell Medical's Change in Account Payables stood at $23000.0, which was up 10310.81% from -$423000.0 recorded in Q2 2025.
  • In the past 5 years, Rockwell Medical's Change in Account Payables ranged from a high of $1.6 million in Q2 2021 and a low of -$2.0 million during Q3 2023
  • Its 5-year average for Change in Account Payables is -$138421.1, with a median of $23000.0 in 2025.
  • Examining YoY changes over the last 5 years, Rockwell Medical's Change in Account Payables showed a top increase of 75526.32% in 2021 and a maximum decrease of 294166.67% in 2021.
  • Quarter analysis of 5 years shows Rockwell Medical's Change in Account Payables stood at -$1.1 million in 2021, then surged by 191.51% to $1.0 million in 2022, then crashed by 41.42% to $587000.0 in 2023, then tumbled by 55.37% to $262000.0 in 2024, then plummeted by 91.22% to $23000.0 in 2025.
  • Its Change in Account Payables stands at $23000.0 for Q3 2025, versus -$423000.0 for Q2 2025 and -$944000.0 for Q1 2025.